Literature DB >> 21126286

Association between chronic kidney disease and small residual urine volumes in patients with benign prostatic hyperplasia.

Takeshi Yamasaki1, Toshihide Naganuma, Taro Iguchi, Yoshikazu Kuroki, Nobuyuki Kuwabara, Yoshiaki Takemoto, Tetsuo Shoji, Tatsuya Nakatani.   

Abstract

AIM: It has been well described that large residual urine volumes (≥300 mL) affect renal function in advanced benign prostatic hyperplasia (BPH). However, it is not clear whether small residual urine volumes (<100 mL) are related to renal function. The present study was performed to examine the association between chronic kidney disease (CKD) and the post-void residual urine volume (PVR) in BPH patients.
METHODS: A cross-sectional study was performed in 160 consecutive BPH patients with PVR of less than 100 mL. We first determined the stage of CKD and compared the PVR in subjects with/without CKD. Next, we divided the subjects into three groups according to the extent of PVR (PVR < 12 mL, 12 mL ≤ PVR < 50 mL, 50 mL ≤ PVR < 100 mL) and compared the estimated glomerular filtration rate (eGFR) among these groups. Moreover, risk factors associated with CKD, including the presence of post-void residual urine, were explored by multiple logistic regression analysis.
RESULTS: The PVR of the patients with CKD was significantly greater than that of the patients without CKD. The group with the normal PVR (group PVR < 12 mL) had a significantly higher eGFR compared with the other two groups. Multivariate analysis demonstrated that the presence of post-void residual urine (PVR ≥ 12 mL) was a significant and independent risk factor associated with the presence of CKD.
CONCLUSION: In BPH patients, the PVR of the patients with CKD was significantly greater than that of the patients without CKD and the presence of post-void residual urine (PVR ≥ 12 mL) was independently associated with CKD, indicating a close association between CKD and small residual urine volumes.
© 2011 The Authors. Nephrology © 2011 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Year:  2011        PMID: 21126286     DOI: 10.1111/j.1440-1797.2010.01430.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  7 in total

Review 1.  Non-neurogenic Chronic Urinary Retention: What Are We Treating?

Authors:  John T Stoffel
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

2.  Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.

Authors:  Chu-Wen Fang; Cheng-Hsi Liao; Shih-Chi Wu; Chih-Hsin Muo
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

3.  Effect of pravastatin and fosinopril on recurrent urinary tract infections.

Authors:  Koen B Pouwels; Sipke T Visser; Eelko Hak
Journal:  J Antimicrob Chemother       Date:  2012-10-30       Impact factor: 5.790

4.  Beyond prostate, beyond surgery and beyond urology: The "3Bs" of managing non-neurogenic male lower urinary tract symptoms.

Authors:  Qixiang Song; Paul Abrams; Yinghao Sun
Journal:  Asian J Urol       Date:  2017-11-23

5.  Current status and progression of lower urinary tract symptoms in Chinese male patients: the protocol and rationale for a nationwide, hospital-based, prospective, multicentre study.

Authors:  Qi-Xiang Song; Yi Zhang; Xiaofei Ye; Wei Xue; Chuanliang Xu; Jing Xu; Paul Abrams; Yinghao Sun
Journal:  BMJ Open       Date:  2019-09-27       Impact factor: 2.692

6.  Association of Lower Urinary Tract Symptom Severity with Kidney Function among Community Dwelling Older Men.

Authors:  Scott R Bauer; Rebecca Scherzer; Shoujun Zhao; Benjamin N Breyer; Stacey A Kenfield; Michael Shlipak; Lynn M Marshall
Journal:  J Urol       Date:  2020-06-28       Impact factor: 7.450

7.  Bilateral ureteral obstruction revealing a benign prostatic hypertrophy: a case report and review of the literature.

Authors:  Omar Riyach; Mustapha Ahsaini; Youssef Kharbach; Mohammed Bounoual; Mohammed Fadl Tazi; Jalal Eddine El Ammari; Soufiane Mellas; Mohammed El Jamal Fassi; Abdelhak Khallouk; Moulay Hassan Farih
Journal:  J Med Case Rep       Date:  2014-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.